Nuvation Bio Inc’s recent filing unveils that its Director Mashal Robert acquired Company’s shares for reported $0.17 million on Apr 01 ’25. In the deal valued at $1.67 per share,100,000 shares were bought. As a result of this transaction, Mashal Robert now holds 200,000 shares worth roughly $0.33 million.
Then, Wang Junyuan Jerry sold 56,361 shares, generating $162,883 in total proceeds. Upon selling the shares at $2.89, the CEO, ANHEART THERAPEUTICS LTD. now owns 3,866,228 shares.
Before that, Mashal Robert bought 100,000 shares. Nuvation Bio Inc shares valued at $220,000 were divested by the Director at a price of $2.20 per share. As a result of the transaction, Mashal Robert now holds 100,000 shares, worth roughly $0.17 million.
Jefferies upgraded its Nuvation Bio Inc [NUVB] rating to a Buy from a a Hold in a research note published on March 27, 2024; the price target was increased to $10 from $1.40. A number of analysts have revised their coverage, including BTIG Research’s analysts, who increased its forecast for the stock in late March from “a Neutral” to “a Buy”. Jefferies also remained covering NUVB and has decreased its forecast on January 06, 2023 with a “Hold” recommendation from previously “Buy” rating. BTIG Research revised its rating on August 02, 2022. It rated NUVB as “a Neutral” which previously was an “a Buy”.
Price Performance Review of NUVB
On Friday, Nuvation Bio Inc [NYSE:NUVB] saw its stock unchanged to $1.66. Over the last five days, the stock has lost -8.79%. Nuvation Bio Inc shares have fallen nearly -37.59% since the year began. Nevertheless, the stocks have fallen -54.27% over the past one year. While a 52-week high of $3.97 was reached on 01/07/25, a 52-week low of $1.64 was recorded on 04/04/25. SMA at 50 days reached $2.1034, while 200 days put it at $2.6369.
Levels Of Support And Resistance For NUVB Stock
The 24-hour chart illustrates a support level at 1.5900, which if violated will result in even more drops to 1.5200. On the upside, there is a resistance level at 1.7100. A further resistance level may holdings at 1.7600. The Relative Strength Index (RSI) on the 14-day chart is 31.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1452, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.69%. Stochastics %K at 13.64% indicates the stock is a buying.
How much short interest is there in Nuvation Bio Inc?
A steep rise in short interest was recorded in Nuvation Bio Inc stocks on 2025-03-14, growing by 2.22 million shares to a total of 28.39 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 26.17 million shares. There was a rise of 7.82%, which implies that there is a positive sentiment for the stock.
